Cancer cells can develop resistance to platinum-based compounds through various mechanisms. One common mechanism is the increased repair of DNA damage caused by the drugs. Cancer cells may also decrease the uptake of the drug or increase its efflux out of the cell, thereby reducing the drug's effectiveness. Understanding these mechanisms is vital for developing strategies to overcome resistance.
